Sept 18, 2017 – The Rosetrees Trust Interdisciplinary Prize for 2017 has been awarded to two scientists from the Hebrew University of Jerusalem, Prof. Yaakov Nahmias

Going under sedation for an operation can sometimes be riskier than the surgical procedure itself. It’s not a problem with the anesthetic. Rather, “drug-induced respiratory depression

Sept 11, 2017 – Medical equipment company Medtronic will be the first company to establish development centers in Israel in cooperation with the Israel Innovation

Jerusalem, Israel – Sept. 11, 2017 – The Iowa Economic Development Authority mission, led by Iowa Governor Kim Reynolds, met with representatives of Jerusalem’s bio-medical

Sept 13, 2017 – Entera is developing a drug for the treatment of osteoporosis. After announcing its general plan for a Nasdaq IPO, as well

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) signed a lease agreement for a commercial facility in Jerusalem to manufacture its universal flu vaccine. BiondVax Pharmaceuticals Ltd. also announced in

If you are over 50, and suffer from dry AMD (dry form, age-related macular degeneration), you may be eligible to join our clinical trial using

Aug 22 2017 – Jerusalem based Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced the Company’s financial results for

Aug 22 – Prof Yakov Nahmias’s human-on-a-chip platform has the unique ability to predict risk of toxicity in pharma and cosmetic product candidates without animal